002940 昂利康
已收盘 09-02 15:00:00
资讯
新帖
简况
昂利康（002940）2026年中报简析：净利润同比下降16.68%
证券之星 · 08-26
昂利康（002940）2026年中报简析：净利润同比下降16.68%
股市必读：昂利康中报 - 第二季度单季净利润同比下降25.49%
证券之星 · 08-26
股市必读：昂利康中报 - 第二季度单季净利润同比下降25.49%
昂利康(002940.SZ)发布半年度业绩，归母净利润5492.64万元，同比下降16.68%
智通财经 · 08-24
昂利康(002940.SZ)发布半年度业绩，归母净利润5492.64万元，同比下降16.68%
昂利康（002940）披露2026年半年度报告，8月24日股价下跌4.17%
证券之星 · 08-24
昂利康（002940）披露2026年半年度报告，8月24日股价下跌4.17%
股市必读：昂利康新发布《2025年度向特定对象发行A股股票募集说明书（注册稿）》
证券之星 · 08-24
股市必读：昂利康新发布《2025年度向特定对象发行A股股票募集说明书（注册稿）》
昂利康最新公告：向特定对象发行股票获证监会同意注册批复
证券之星 · 08-20
昂利康最新公告：向特定对象发行股票获证监会同意注册批复
股市必读：昂利康新发布《关于参与第十二批全国药品集中带量采购拟中选的公告》
证券之星 · 08-03
股市必读：昂利康新发布《关于参与第十二批全国药品集中带量采购拟中选的公告》
昂利康最新公告：西格列汀二甲双胍缓释片等3个产品拟中选第十二批国家集采
证券之星 · 08-02
昂利康最新公告：西格列汀二甲双胍缓释片等3个产品拟中选第十二批国家集采
昂利康最新公告：获得洛索洛芬钠凝胶贴膏药品注册证书
证券之星 · 07-24
昂利康最新公告：获得洛索洛芬钠凝胶贴膏药品注册证书
7月24日昂利康跌6.63%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 07-24
7月24日昂利康跌6.63%，国泰海通新锐量化选股混合A基金重仓该股
昂利康（002940）披露关于对外投资的议案，7月22日股价上涨0.85%
证券之星 · 07-22
昂利康（002940）披露关于对外投资的议案，7月22日股价上涨0.85%
7月21日昂利康跌6.36%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 07-21
7月21日昂利康跌6.36%，国泰海通新锐量化选股混合A基金重仓该股
7月17日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 07-17
7月17日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股
异动快报：昂利康（002940）7月17日10点49分触及跌停板
证券之星 · 07-17
异动快报：昂利康（002940）7月17日10点49分触及跌停板
7月15日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 07-15
7月15日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股
半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起
格隆汇 · 07-15
半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起
昂利康（002940）披露2025年度向特定对象发行A股股票募集说明书（注册稿），7月8日股价下跌3.66%
证券之星 · 07-08
昂利康（002940）披露2025年度向特定对象发行A股股票募集说明书（注册稿），7月8日股价下跌3.66%
昂利康（002940）披露增加2026年度日常关联交易预计额度公告，7月6日股价上涨3.61%
证券之星 · 07-06
昂利康（002940）披露增加2026年度日常关联交易预计额度公告，7月6日股价上涨3.61%
昂利康最新公告：向特定对象发行股票申请获深交所审核通过
证券之星 · 07-01
昂利康最新公告：向特定对象发行股票申请获深交所审核通过
7月1日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 07-01
7月1日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股
公司概况
公司名称：
浙江昂利康制药股份有限公司
所属行业：
医药制造业
上市日期：
2018-10-23
主营业务：
浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是口服头孢类抗生素原料药、alpha酮酸原料药、吸入用麻醉原料药、抗雄性激素中间体。
发行价格：
23.07
{"stockData":{"symbol":"002940","market":"SZ","secType":"STK","nameCN":"昂利康","latestPrice":26.03,"timestamp":1788332625000,"preClose":24.71,"halted":0,"volume":13937766,"delay":0,"changeRate":0.0534,"floatShares":185000000,"shares":202000000,"eps":0.5674,"marketStatus":"已收盘","change":1.32,"latestTime":"09-02 15:00:00","open":24.72,"high":26.54,"low":24.21,"amount":354000000,"amplitude":0.0943,"askPrice":26.03,"askSize":1524,"bidPrice":26.02,"bidSize":112,"shortable":0,"etf":0,"ttmEps":0.5674,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":5,"adr":0,"adjPreClose":24.71,"symbolType":"stock","openAndCloseTimeList":[[1788312600000,1788319800000],[1788325200000,1788332400000]],"highLimit":27.18,"lowLimit":22.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201728186,"isCdr":false,"pbRate":3.01,"roa":"--","peRate":45.875925,"roe":"3.33%","epsLYR":0.62,"committee":-0.541151,"marketValue":5251000000,"turnoverRate":0.0755,"status":0,"floatMarketCap":4807000000},"requestUrl":"/m/hq/s/002940/wiki","defaultTab":"wiki","newsList":[{"id":"2662509217","title":"昂利康（002940）2026年中报简析：净利润同比下降16.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662509217?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:27","pubTimestamp":1787696827,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昂利康发布2026年中报。根据财报显示，昂利康净利润同比下降16.68%。截至本报告期末，公司营业总收入6.27亿元，同比下降13.44%，归母净利润5492.64万元，同比下降16.68%。按单季度数据看，第二季度营业总收入2.87亿元，同比下降24.27%，第二季度归母净利润3727.16万元，同比下降25.49%。其他应收款变动幅度为158.3%,原因:截至报告期末昂利康胶囊股权转让款尚未全部收回。应付票据变动幅度为41.87%,原因:开具的银行承兑汇票支付货款增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752881","title":"股市必读：昂利康中报 - 第二季度单季净利润同比下降25.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752881","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662752881?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:27","pubTimestamp":1787689630,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润3727.16万元，同比下降25.49%；扣非净利润2076.32万元，同比下降40.56%。公司公告汇总2026年半年度报告摘要浙江昂利康制药股份有限公司2026年半年度报告摘要显示，本报告期营业收入为627,033,693.79元，较上年同期减少13.44%；归属于上市公司股东的净利润为54,926,353.41元，同比减少16.68%；归属于上市公司股东的扣除非经常性损益的净利润为36,805,556.78元，同比减少15.77%；经营活动产生的现金流量净额为138,484,063.73元，同比增长57.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600007968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661277184","title":"昂利康(002940.SZ)发布半年度业绩，归母净利润5492.64万元，同比下降16.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661277184","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661277184?lang=zh_cn&edition=full","pubTime":"2026-08-24 23:20","pubTimestamp":1787584815,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)发布2026年半年度报告，报告期内，公司实现营业总收入6.27亿元，同比下降13.44%;归属于上市公司股东的净利润5492.64万元，同比下降16.68%;归属于上市公司股东的扣除非经常性损益的净利润3680.56万元，同比下降15.77%;基本每股收益0.27元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"昂利康(002940.SZ)发布半年度业绩，归母净利润5492.64万元，同比下降16.68%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272466","title":"昂利康（002940）披露2026年半年度报告，8月24日股价下跌4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272466","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272466?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:43","pubTimestamp":1787582596,"startTime":"0","endTime":"0","summary":"近日，浙江昂利康制药股份有限公司披露《2026年半年度报告》。本报告期末总资产为2,975,889,883.53元，较上年度末增长0.85%；归属于上市公司股东的净资产为1,654,693,407.75元，较上年度末增长1.69%。公司控股股东和实际控制人在报告期内未发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661203243","title":"股市必读：昂利康新发布《2025年度向特定对象发行A股股票募集说明书（注册稿）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661203243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661203243?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:12","pubTimestamp":1787505133,"startTime":"0","endTime":"0","summary":"公司公告汇总：昂利康收到证监会《关于同意向特定对象发行股票注册的批复》，批复有效期12个月。公司公告汇总2025年度向特定对象发行A股股票募集说明书（注册稿）浙江昂利康制药股份有限公司拟向特定对象发行A股股票，募集资金111,000.00万元，扣除发行费用后全部用于创新药研发项目；发行数量不超过60,518,455股，不超过发行前公司总股本的30%；发行对象为不超过35名符合资格的特定投资者，限售期6个月；本次发行不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03188","02846","82846","BK1147","03130","399300","83130","83188","07233","159982","02827","002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660328392","title":"昂利康最新公告：向特定对象发行股票获证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660328392","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660328392?lang=zh_cn&edition=full","pubTime":"2026-08-20 18:10","pubTimestamp":1787220627,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司收到证监会出具的《关于同意浙江昂利康制药股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股票的注册申请。本次发行应严格按照报送深交所的申报文件和发行方案实施，批复自同意注册之日起12个月内有效。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000033253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656762348","title":"股市必读：昂利康新发布《关于参与第十二批全国药品集中带量采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656762348","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656762348?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:58","pubTimestamp":1785693491,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，昂利康报收于24.34元，上涨3.97%，换手率5.31%，成交量9.84万手，成交额2.38亿元。公司公告汇总关于参与第十二批全国药品集中带量采购拟中选的公告浙江昂利康制药股份有限公司及子公司福建海西联合药业有限公司参与第十二批全国药品集中带量采购，吸入用七氟烷、西格列汀二甲双胍缓释片、沙库巴曲缬沙坦钠片拟中选。2025年度上述产品销售额合计约5,068万元，占公司营业总收入的3.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656312744","title":"昂利康最新公告：西格列汀二甲双胍缓释片等3个产品拟中选第十二批国家集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2656312744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656312744?lang=zh_cn&edition=full","pubTime":"2026-08-02 16:20","pubTimestamp":1785658824,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司及子公司海西药业参与第十二批全国药品集中带量采购，西格列汀二甲双胍缓释片、沙库巴曲缬沙坦钠片及吸入用七氟烷拟中选。上述产品2025年度销售额合计约5068万元，占公司营收的3.56%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200006700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653083549","title":"昂利康最新公告：获得洛索洛芬钠凝胶贴膏药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2653083549","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653083549?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:40","pubTimestamp":1784886056,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司收到国家药监局签发的洛索洛芬钠凝胶贴膏《药品注册证书》，该药品用于骨关节炎、肌肉痛、外伤后的肿胀疼痛等消炎镇痛。本次获批视同通过一致性评价，将进一步丰富公司仿制药产品管线，增强综合竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400030860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653470097","title":"7月24日昂利康跌6.63%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653470097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653470097?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:49","pubTimestamp":1784882982,"startTime":"0","endTime":"0","summary":"证券之星消息，7月24日昂利康跌6.63%创60日新低，收盘报23.65元，换手率6.39%，成交量11.83万手，成交额2.86亿元。国泰海通新锐量化选股混合A目前规模为0.32亿元，最新净值1.2107，较上一交易日上涨1.25%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0012","BK0184","002940","BK1564","02611","601211","BK0183","BK0188","BK0028","BK0201","BK1147","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653765050","title":"昂利康（002940）披露关于对外投资的议案，7月22日股价上涨0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653765050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653765050?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:15","pubTimestamp":1784729721,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，昂利康报收于24.93元，较前一交易日上涨0.85%，最新总市值为50.29亿元。该股当日开盘24.1元，最高25.7元，最低23.9元，成交额达3.54亿元，换手率为7.64%。近日，浙江昂利康制药股份有限公司召开第四届董事会第二十次会议，审议通过《关于对外投资的议案》。本次投资金额占公司最近一期经审计净资产的3.0726%，未达到披露标准，无需单独公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653220746","title":"7月21日昂利康跌6.36%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653220746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653220746?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:50","pubTimestamp":1784623839,"startTime":"0","endTime":"0","summary":"证券之星消息，7月21日昂利康跌6.36%创60日新低，收盘报24.72元，换手率11.52%，成交量21.33万手，成交额5.24亿元。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.178，较上一交易日下跌4.31%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100030945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","601211","002940","BK1147","02611","BK0012","BK0184","BK0201","BK1564","BK0276","BK0188","BK0239","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652740697","title":"7月17日昂利康跌10.00%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652740697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652740697?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:47","pubTimestamp":1784278045,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日昂利康跌10.00%，收盘报27.01元，换手率12.03%，成交量22.28万手，成交额6.28亿元。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.317，较上一交易日下跌1.94%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0184","BK0188","BK0183","002940","601211","BK0028","02611","BK0239","BK1564","BK0276","BK1147","BK0201","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652479557","title":"异动快报：昂利康（002940）7月17日10点49分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652479557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652479557?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:50","pubTimestamp":1784256636,"startTime":"0","endTime":"0","summary":"证券之星7月17日盘中消息，10点49分昂利康（002940）触及跌停板。其所属行业化学制药目前下跌。领涨股为哈药股份。该股为宠物经济，合成生物，医药概念热股。7月16日的资金流向数据方面，主力资金净流出213.61万元，占总成交额0.2%，游资资金净流入434.85万元，占总成交额0.4%，散户资金净流出221.24万元，占总成交额0.2%。近5日资金流向一览见下表：昂利康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700014520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453207","title":"7月15日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651453207?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:32","pubTimestamp":1784104347,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日昂利康涨10.00%，收盘报28.94元，换手率7.13%，成交量13.2万手，成交额3.71亿元。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.3538，较上一交易日上涨2.0%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0184","02611","601211","BK1564","002940","BK0012","BK0183","BK0028","BK0201","BK1147","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651879434","title":"半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起","url":"https://stock-news.laohu8.com/highlight/detail?id=2651879434","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651879434?lang=zh_cn&edition=full","pubTime":"2026-07-15 13:50","pubTimestamp":1784094601,"startTime":"0","endTime":"0","summary":"政策密集加码","market":"hk","thumbnail":"https://img3.gelonghui.com/9d73a-d7eab21c-e179-4850-9c4c-edf64e1fd8eb.jpg?guru_height=716&guru_width=1280&guru_size=127989","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9d73a-d7eab21c-e179-4850-9c4c-edf64e1fd8eb.jpg?guru_height=716&guru_width=1280&guru_size=127989"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5584162","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0146","000566","002317","BK0028","300149","600664","002940","BK0012","BK0077","06978","BK0216","BK0060","BK1574","BK0070","IBBQ","159992","BD","688192","MEDX","BK0188","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649946669","title":"昂利康（002940）披露2025年度向特定对象发行A股股票募集说明书（注册稿），7月8日股价下跌3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649946669","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649946669?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:21","pubTimestamp":1783520479,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，昂利康报收于26.57元，较前一交易日下跌3.66%，最新总市值为53.6亿元。该股当日开盘27.4元，最高28.2元，最低26.5元，成交额达3.23亿元，换手率为6.4%。近日，浙江昂利康制药股份有限公司披露《2025年度向特定对象发行A股股票募集说明书（注册稿）》。公告显示，公司拟向特定对象发行A股股票，募集资金111,000.00万元，全部用于创新药研发项目。本次发行股票数量不超过60,518,455股，发行对象为不超过35名符合资格的特定投资者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","159982","BK0239","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649627812","title":"昂利康（002940）披露增加2026年度日常关联交易预计额度公告，7月6日股价上涨3.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649627812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649627812?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:09","pubTimestamp":1783346952,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，昂利康报收于30.4元，较前一交易日上涨3.61%，最新总市值为61.33亿元。该股当日开盘29.05元，最高31.92元，最低28.89元，成交额达8.4亿元，换手率为14.96%。近日，浙江昂利康制药股份有限公司发布《关于增加2026年度日常关联交易预计额度的公告》。本次调整后，公司与关联方2026年度日常关联交易预计总额由1,407万元增至1,707万元（不含税）。关联交易遵循市场定价原则，不存在损害公司及股东利益的情形，不影响公司独立性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648708548","title":"昂利康最新公告：向特定对象发行股票申请获深交所审核通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2648708548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648708548?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:20","pubTimestamp":1782908406,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司于2026年7月1日收到深交所上市审核中心出具的审核中心意见告知函，认为公司符合发行条件、上市条件和信息披露要求，后续将按规定报证监会履行注册程序。该事项尚需证监会同意注册后方可实施，存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648451694","title":"7月1日昂利康涨10.00%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648451694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648451694?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:49","pubTimestamp":1782895778,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日昂利康涨10.00%，收盘报29.05元，换手率11.42%，成交量21.15万手，成交额5.91亿元。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.4761，较上一交易日上涨2.85%。国泰海通新锐量化选股混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","601211","BK0276","BK0012","BK0028","BK0183","BK1564","BK0184","BK1147","02611","BK0201","BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788359811378,"stockEarnings":[{"period":"1week","weight":-0.043},{"period":"1month","weight":0.0152},{"period":"3month","weight":-0.2836},{"period":"6month","weight":-0.1699},{"period":"1year","weight":-0.4919},{"period":"ytd","weight":-0.2591}],"compareEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.0385},{"period":"3month","weight":-0.0255},{"period":"6month","weight":-0.0313},{"period":"1year","weight":0.0269},{"period":"ytd","weight":0.0028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江昂利康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36257人(较上一季度减少9.88%)","perCapita":"5093股","listingDate":"2018-10-23","address":"浙江省绍兴市嵊州市嵊州大道北1000号","registeredCapital":"20172万元","survey":" 浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是口服头孢类抗生素原料药、alpha酮酸原料药、吸入用麻醉原料药、抗雄性激素中间体。","listedPrice":23.07},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昂利康,002940,昂利康股票,昂利康股票老虎,昂利康股票老虎国际,昂利康行情,昂利康股票行情,昂利康股价,昂利康股市,昂利康股票价格,昂利康股票交易,昂利康股票购买,昂利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}